Anti-proliferative effects of rutin on OLETF rat vascular smooth muscle cells stimulated by glucose variability

Yonsei Medical Journal

Volumn 57, Issue 2, 2016, Pages 373-381

  Yu, Sung Hoon ^a   Yu, Jae Myung ^a   Yoo, Hyung Joon ^a   Lee, Seong Jin ^a   Kang, Dong Hyun ^a   Kim, Doo Man ^a   Cho, Young Jung ^b  

^a Hallym University College of Medicine   (South Korea)

^b National Medical Center   (South Korea)

Author keywords

Hyperglycemia; Mitogen activated protein kinases; Phosphatidylinositol 3 kinase; Rutin; Smooth muscle cells

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; RUTOSIDE; STRESS ACTIVATED PROTEIN KINASE; FLAVONOID; GLUCOSE; MAP2K1 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; GLUCOSE METABOLISM; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN EXPRESSION; SPECTROFLUOROMETRY; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANIMAL; CELL MOTION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; LONG EVANS RAT; MALE; METABOLISM; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; RAT; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CASPASE 3; CELL MOVEMENT; CELL PROLIFERATION; FLAVONOIDS; GLUCOSE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED OLETF; RATS, LONG-EVANS; REACTIVE OXYGEN SPECIES; RUTIN;

EID: 84956878197     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2016.57.2.373     Document Type: Article

References (31)

1. Singh A, Donnino R, Weintraub H, Schwartzbard A. Effect of strict glycemic control in patients with diabetes mellitus on frequency of macrovascular events. Am J Cardiol 2013;112:1033-8.
2. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91.
3. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res 1986;58:427-44.
4. Bonora E, Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 2001;44:2107-14.
5. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295:1681-7.
6. Choi KW, Park HJ, Jung DH, Kim TW, Park YM, Kim BO, et al. Inhibition of TNF-α-induced adhesion molecule expression by diosgenin in mouse vascular smooth muscle cells via downregulation of the MAPK, Akt and NF-κB signaling pathways. Vascul Pharmacol 2010;53:273-80.
7. Park S, Lim S, Chang W, Song H, Lee S, Song BW, et al. The inhibition of insulin-stimulated proliferation of vascular smooth muscle cells by rosiglitazone is mediated by the Akt-mTOR-P70S6K pathway. Yonsei Med J 2008;49:592-600.
8. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia- induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999;48:855-64.
9. Yoshizumi M, Kyotani Y, Zhao J, Nagayama K, Ito S, Tsuji Y, et al. Role of big mitogen-activated protein kinase 1 (BMK1) / extracellular signal-regulated kinase 5 (ERK5) in the pathogenesis and pro- gression of atherosclerosis. J Pharmacol Sci 2012;120:259-63.
10. Yoo HJ, Kozaki K, Akishita M, Watanabe M, Eto M, Nagano K, et al. Augmented Ca2+ influx is involved in the mechanism of enhanced proliferation of cultured vascular smooth muscle cells from spontaneously diabetic Goto-Kakizaki rats. Atherosclerosis 1997;131: 167-75.
11. Bochaton-Piallat ML, Ropraz P, Gabbiani F, Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 1996;16:815-20.
12. Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 2006;545:51-64.
13. Belcaro G, Cesarone MR, Ledda A, Cacchio M, Ruffini I, Ricci A, et al. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry. Angiology 2008;59 Suppl 1:14S-20S.
14. Rodrigues AM, Marcilio Fdos S, Frazao Muzitano M, Giraldi-Guimaraes A. Therapeutic potential of treatment with the flavonoid rutin after cortical focal ischemia in rats. Brain Res 2013;1503:53-61.
15. Prochazkova D, Boušova I, Wilhelmova N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia 2011;82:513-23.
16. Araujo JR, Goncalves P, Martel F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr Res 2011;31:77-87.
17. Kulisić T, Krisko A, Dragović-Uzelac V, Milos M, Pifat G. The effects of essential oils and aqueous tea infusions of oregano (Origanum vulgare L. spp. hirtum), thyme (Thymus vulgaris L.) and wild thyme (Thymus serpyllum L.) on the copper-induced oxidation of human low-density lipoproteins. Int J Food Sci Nutr 2007;58: 87-93.
18. Hsu IP, Jou HJ, Huang CW, Wang TA, Wu WH. The effects of soygerm extracts on blood lipoproteins, antioxidative capacity and urinary estrogen metabolites in postmenopausal women on hormone therapy. Int J Gynaecol Obstet 2007;98:29-33.
19. Botelho FV, Alvarez-Leite JI, Lemos VS, Pimenta AM, Calado HD, Matencio T, et al. Physicochemical study of floranol, its copper(II) and iron(III) complexes, and their inhibitory effect on LDL oxidation. J Inorg Biochem 2007;101:935-43.
20. Milde J, Elstner EF, Grassmann J. Synergistic effects of phenolics and carotenoids on human low-density lipoprotein oxidation. Mol Nutr Food Res 2007;51:956-61.
21. Alipui C, Ramos K, Tenner TE Jr. Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus. Cardiovasc Res 1993; 27:1229-32.
22. Natarajan R, Gonzales N, Xu L, Nadler JL. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem Biophys Res Commun 1992;187:552-60.
23. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287:2570-81.
24. Natali A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 2000;43:632-41.
25. Wang C, Lv L, Yang Y, Chen D, Liu G, Chen L, et al. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2012;76:810-5.
26. Kim M, Chung H, Yoon C, Lee E, Kim T, Kim T, et al. Increase of INS-1 cell apoptosis under glucose fluctuation and the involvement of FOXO-SIRT pathway. Diabetes Res Clin Pract 2012;98:132-9.
27. Jasuja R, Passam FH, Kennedy DR, Kim SH, van Hessem L, Lin L, et al. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest 2012;122:2104-13.
28. Lee WH, Ku SK, Bae JS. Barrier protective effects of rutin in LPSinduced inflammation in vitro and in vivo. Food Chem Toxicol 2012; 50:3048-55.
29. Jeong JJ, Ha YM, Jin YC, Lee EJ, Kim JS, Kim HJ, et al. Rutin from Lonicera japonica inhibits myocardial ischemia/reperfusion-induced apoptosis in vivo and protects H9c2 cells against hydrogen peroxide-mediated injury via ERK1/2 and PI3K/Akt signals in vitro. Food Chem Toxicol 2009;47:1569-76.
30. Ruiz E, Padilla E, Redondo S, Gordillo-Moscoso A, Tejerina T. Kaempferol inhibits apoptosis in vascular smooth muscle induced by a component of oxidized LDL. Eur J Pharmacol 2006;529:79-83.
31. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol 1999;71: 479-500.